The largest database of trusted experimental protocols
> Physiology > Cell Function > Cellular Senescence

Cellular Senescence

Cellular senescence is a fundamental biological process characterized by the gradual deterioration and permanent arrest of cell division.
This phenotype is triggered by various intrinsic and extrinsic factors, such as telomere attrition, DNA damage, oxidative stress, and oncogenic signaling.
Senescent cells exhibit distinct morphological and functional changes, including enlarged and flattened morphology, increased senescence-associated β-galactosidase activity, and the secretion of a pro-inflammatory senescence-associated secretory phenotype (SASP).
Cellular senescence plays a crucial role in organismal aging, tissue homeostasis, and the development of age-related diseases.
Understanfing the mechanisms and regulators of cellular senescence is crucial for developing targeted interventions to mitigate the detrimental effects of this process and promote healthy aging.
The study of cellular senescence has important implications for fields such as regenerative medicine, cancer biology, and age-related disease research.

Most cited protocols related to «Cellular Senescence»

Severity scores were created by dividing the pool of assessments from individuals with ASD into narrowly defined age and language cells, and standardizing raw total scores from the revised algorithms (Gotham et al., 2007 ) within these cells. In order to maximize the number of cases available for standardization, assessments missing data from any one item from either the Social Affect (SA) or Restricted Repetitive Behavior (RRB) domains of the revised ADOS algorithms were retained by adding to the domain total an average item score from that participant’s existing domain data. The ASD sample alone was used for raw total standardization: this included all assessments corresponding to a best estimate diagnosis of autism or ASD, as well as data from 13 individuals who had ADOS data with a contemporaneous nonspectrum diagnosis but who were later diagnosed with ASD. This subsample (N=1807 assessments from 1118 individuals) was separated into groups based on the five revised algorithms used with children: Module 1 No Words, Module 1 Some Words, Module 2 Younger than 5; Module 2 Age 5 and Older; and Module 3. Within each of these five developmental cells, distributions of summed Social Affect and Restricted Repetitive Behaviors totals were generated separately for every one-year age group between 2 and 16 years; these age cells were collapsed when possible in order to create the fewest number of age- and language-level-determined ‘calibration cells’ with similar raw total score distributions. Younger age cells were purposely kept distinct to anticipate developmental changes and more frequent assessments in young children as they transition from toddlerhood to preschool to school programs. Age cells with similar distributions were collapsed only within the same algorithm. Eighteen calibration cells resulted (see Figure 1).
Within each of these 18 cells, raw ADOS totals were mapped onto a 10-point severity metric. After considering a variety of approaches, severity scores 1–3 were set so as to represent the distribution of raw scores receiving a nonspectrum ADOS classification within that calibration cell, severity scores 4–5 represented ASD-classification ADOS totals, and 6–10 represented raw totals receiving an autism classification within that cell. ADOS classification thresholds were determined by the revised algorithm relevant to each calibration cell. The range of raw totals corresponding to each point on the severity metric was determined by the percentiles of available data associated with each severity point within a classification range. Lower severity scores are associated with less autism impairment. Table 2 shows the raw score range corresponding to each severity point within each calibration cell.
Publication 2008
Adenosine Age Groups Autistic Disorder Cells Cellular Senescence Child Child, Preschool Youth
Table 2 provides an overview of our measures of epigenetic age acceleration. The universal measure of age acceleration (AgeAccel), which is valid for a wide range of tissue types, is defined as the residual resulting from a linear regression model that regresses the Horvath estimate of epigenetic age on chronological age. Thus, a positive value for AgeAccel indicates that the observed epigenetic age is higher than that predicted, based on chronological age. AgeAccel has a relatively weak correlation with blood cell counts [25 (link)], but it still relates to estimated blood cell counts, as seen in Supplementary Table 4.
To estimate “pure” epigenetic aging effects that are not influenced by differences in blood cell counts (“intrinsic” epigenetic age acceleration, IEAA), we obtained the residual resulting from a multivariate regression model of epigenetic age on chronological age and various blood immune cell counts (naive CD8+ T cells, exhausted CD8+ T cells, plasmablasts, CD4+ T cells, natural killer cells, monocytes, and granulocytes) imputed from methylation data.
Extrinsic epigenetic age acceleration measures capture both cell intrinsic methylation changes and extracellular changes in blood cell composition. Our measure of EEAA is defined using the following three steps. First, we calculated the epigenetic age measure from Hannum et al [2 (link)], which already correlated with certain blood cell types [5 (link)]. Second, we increased the contribution of immune blood cell types to the age estimate by forming a weighted average of Hannum's estimate with 3 cell types that are known to change with age: naïve (CD45RA+CCR7+) cytotoxic T cells, exhausted (CD28-CD45RA-) cytotoxic T cells, and plasmablasts using the Klemera-Doubal approach [32 (link)]. The weights used in the weighted average are determined by the correlation between the respective variable and chronological age [32 (link)]. The weights were chosen on the basis of the WHI data. Thus, the same (static) weights were used for all data sets. EEAA was defined as the residual variation resulting from a univariate model regressing the resulting age estimate on chronological age. By construction, EEAA is positively correlated with the estimated abundance of exhausted CD8+ T cells, plasmablast cells, and a negative correlated with naive CD8+ T cells. Blood cell counts were estimated based on DNA methylation data as described in the next section. By construction, the measures of EEAA track both age related changes in blood cell composition and intrinsic epigenetic changes. None of our four measures of epigenetic age acceleration are correlated with chronological age.
Full text: Click here
Publication 2016
Acceleration BLOOD Blood Cell Count Blood Cells CD4 Positive T Lymphocytes CD8-Positive T-Lymphocytes Cells Cellular Senescence Cytotoxic T-Lymphocytes Debility Epigenetic Process Granulocyte Histocompatibility Testing Methylation Monocytes Natural Killer Cells Vision
For comparison of colony formation and senescent cells between different genetically manipulated cell strains we used a two-tailed student’s t-test and P < 0.05 was considered significant. mRNA microarray profiling was performed with Illumina HumanHT-12 v4 Expression BeadChips (Illumina Inc., San Diego, CA) following the manufacturer’s guidelines and analyzed with in-house Visual Basic software MATRIX V1.483. Functional analysis of differentially expressed genes was performed using Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, Inc. Redwood City, CA). The data discussed in this publication have been made available in the National Center for Biotechnology Information’s Gene Expression Omnibus (GEO) public repository (http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession number GSE40828. The predictive ability of the soft agar gene signature was tested using two independent mRNA microarray lung tumor datasets; 209 primary lung adenocarcinomas and squamous cell carcinomas (SPORE dataset) GSE41271 and 442 primary lung adenocarcinomas (NCI Director’s Challenge Consortium dataset) (30 (link)). A detailed description of these two datasets and the prediction analysis is given in the supplementary methods.
Publication 2013
Adenocarcinoma of Lung Agar Cellular Senescence Gene Expression Genes Lung Neoplasms Microarray Analysis Redwood RNA, Messenger Spores Squamous Cell Carcinoma Strains Student
Build 1 of CellAge resulted in a total of 279 curated cell senescence genes which we have incorporated into the HAGR suite of aging resources. The HAGR platform comprises a suite of aging databases and analysis scripts. The CellAge interface has been designed with the help of JavaScript libraries to enable more efficient retrieval and combinatorial searches of genes. As with the other HAGR databases, we have used PHP to serve the data via an Apache web server. The raw data can be downloaded via the main HAGR downloads page in CSV format or filtered and downloaded from the main search page.
The first part of our work consisted in finding which genes driving CS are also associated with ARDs or with longevity, using the following data sources:

Human genes associated with CS: CellAge build 1.

Human genes associated with human aging: GenAge human build 19.

Human orthologues of model organisms’ genes associated with longevity: proOrthologuesPub.tsv and antiOrthologuesPub.tsv file (https://github.com/maglab/genage-analysis/blob/master/Dataset_4_aging_genes.zip) [34 (link)].

Human oncogenes: Oncogene database (http://ongene.bioinfo-minzhao.org/index.html).

Human tumor suppressor gene database: TSGene 2.0 (https://bioinfo.uth.edu/TSGene/index.html).

Human genes associated with ARDs (https://github.com/maglab/genage-analysis/blob/master/Dataset_5_disease_genes.zip) [34 (link)]. This data concerns the 21 diseases with the highest number of gene associations, plus asthma, a non-aging-related respiratory system disease used as a control.

Human genes differentially expressed with age from the GTEx project (v7, January 2015 release) [32 (link), 43 (link)].

Full text: Click here
Publication 2020
Asthma Cellular Senescence Genes Hereditary Diseases Homo sapiens Oncogenes Respiratory Distress Syndrome, Adult Respiratory Tract Diseases Tumor Suppressor Genes
We used an epigenetic biomarker of age based on 353 CpG markers as one measure of epigenetic age because: a) it is an accurate measurement of age across multiple tissues [3 (link)]; b) we previously showed that it is predictive of all-cause mortality [5 (link)]; c) it correlated with measures of cognitive/physical fitness and neuro-pathology in the elderly [19 (link),20 (link)]; and d) it was associated with conditions that are of interest in aging research including Down's syndrome [21 (link)], Huntington's disease [22 (link)], Parkinson's disease [23 (link)], obesity [24 (link)], HIV infection [25 (link)], menopause [26 (link)], centenarian status [27 (link)], ethnicity and sex [28 (link)], and cellular senescence [3 (link),29 (link)]. This epigenetic age estimator not only lends itself to measuring aging effects in elderly subjects; but also applies to prenatal brain samples [30 (link)] and blood samples from minors [31 (link)]. Epigenetic age is defined as the predicted value of age based on the DNA methylation levels of 353 CpGs. Mathematical details and software tutorials for estimating epigenetic age can be found in the additional files of [3 (link)]. All of the described epigenetic measures of aging and age acceleration are implemented in our freely available software (https://dnamage.genetics.ucla.edu) [3 (link)].
Full text: Click here
Publication 2016
Acceleration Aged associated conditions Biological Markers BLOOD Brain Cellular Senescence Centenarians Cognition cytidylyl-3'-5'-guanosine DNA Methylation Down Syndrome Ethnicity HIV Infections Huntington Disease Menopause Obesity Parkinson Disease Tissues

Most recents protocols related to «Cellular Senescence»

Example 8

Administration of bleomycin, a DNA damaging agent, to the anterior chamber of the mouse or rabbit eye leads to cellular senescence, as detected by the induction of p16 transcript in the trabecular meshwork.

To induce a senescent phenotype in the trabecular meshwork in vivo, C57Bl/6 mice (aged 8 to 10 weeks) were injected intracamerally with 2 μL of 0.0075 U bleomycin sulfate. In the rabbit, 30 μL of 0.0075 U bleomycin sulfate were injected intracamerally in New Zealand white rabbits. Eyes were enucleated 14 days post-bleomycin injury and TM-enriched samples were micro-dissected. To determine change in senescent cells, RNA was isolated from TM and qPCR analysis was done to assess the effect of bleomycin on p16 mRNA levels.

FIGS. 12A and 12B show elevated relative expression of p16 at 14 days after intracameral (IC) injection of bleomycin in the right (OD) eye relative to the PBS-injected left (OS) eye of the test animals. This model can also be used to assess whether a test compound is pharmacologically capable of reducing or ameliorating the increased intraocular pressure that is a hallmark of primary open angle glaucoma (POAG).

Full text: Click here
Patent 2024
Animal Model Animals Bleomycin Cellular Senescence Chambers, Anterior DNA, A-Form Figs Glaucoma Glaucoma, Primary Open Angle indium-bleomycin Injuries Mice, Inbred C57BL Mus New Zealand Rabbits Phenotype Rabbits RNA, Messenger Sulfate, Bleomycin Tonometry, Ocular Trabecular Meshwork

Example 1

A primary goal of the present invention was to develop yeast strains highly effective at metabolizing galactose. However, galactose-metabolizing yeasts are uncommon; yeasts typically prefer glucose, a carbohydrate source known to strongly suppress the expression of genes needed to metabolize other carbohydrates such as galactose (See Escalante-Chong et al., “Galactose metabolic genes in yeast respond to a ratio of galactose and glucose.” Proc Nat'l Acad Sci, USA 112:1636-41 (2015)). Wild type yeast strains may thus be prevented from utilizing any carbohydrates when glucose is present. Even if a yeast does have the capability to use other carbohydrate sources, it may occur late in the growth process, only after glucose has been completely depleted. Therefore, a particular type of galactose-metabolizing yeast was developed that degrades galactose in the presence of glucose. The present invention provides methods for adaptively evolving yeast according to this process.

To assess the ability of a yeast strain to degrade galactose, its growth was evaluated on media containing galactose in presence or absence of glucose. The following strains were tested: the commercially available strains Saccharomyces cerevisiae (N) (Natureland, Saccharomyces boulardii (SB) (Jarrow, Santa Fe Springs, CA), and Saccharomyces boulardii (B) (Biocodex, Redwood City, CA). Additional strains included in the screening were isolated from food containing large amounts of galactose such as dairy products and legumes stored at room temperature for over two weeks.

Cultures of various strains were initiated from a single colony on agar plates or from glycerol stocks, and grown in liquid YP medium (1% yeast extract, 2% peptone; Teknova) by incubation at 30° C. with agitation at 125 rpm (Murakami & Kaeberlein “Quantifying Yeast Chronological Life Span by Outgrowth of Aged Cells.” J Visual Exp (27) (2009)). Overnight yeast cultures initiated in duplicate in liquid YP medium were used as pre-cultures to initiate growth efficiency experiments in liquid CM (Synthetic Complete Minimal Medium, 0.5% Ammonium Sulfate, Teknova) containing 2% galactose alone as the sole carbon source, 2% glucose alone as the sole carbon source, or galactose and glucose. Culture growth of cultures set at 30° C. under static conditions was monitored over time by measuring optical density (OD) at 600 nm (OD600) using a spectrophotometer.

Growth—was evaluated for several strains. As illustrated in Table 1, one of the evolved clone exhibited the lowest doubling time, which remained at the same level independently of the carbohydrate source and growth conditions.

TABLE 1
Doubling Time of Yeast Strains under Static Growth Conditions
in Media Containing Galactose alone, Glucose alone,
and Galactose and Glucose.
Galactose +
GalactoseGlucoseGlucose
Avg.Avg.Avg.
Strains(h)SD(h)SD(h)SD
Y1_Parent4.570.034.430.054.400.01
Evolved Clone4.050.024.170.084.210.02
Strain N6.050.034.460.024.230.01
Strain SB7.790.064.680.004.750.03
Strain B8.850.024.960.024.630.01
Each data point represents the averages (Avg.) and standard deviation (SD) of quadruplicate values obtained for two independent cultures per strain.

Full text: Click here
Patent 2024
43-63 Agar Carbohydrates Carbon Cellular Senescence Clone Cells Culture Media, Conditioned Dairy Products Fabaceae Food Galactose Gene Expression Genes Glucose Glycerin Growth Disorders hydrocortisone butyrate Natural Springs Parent Peptones Redwood Saccharomyces Saccharomyces boulardii Saccharomyces cerevisiae Strains Sulfate, Ammonium Vision Yeasts
Not available on PMC !

Example 6

The efficacy of model compound UBX1967 was studied in the mouse oxygen-induced retinopathy (OIR) model, which provides an in vivo model of retinopathy of prematurity (ROP) and diabetic retinopathy.

C57Bl/6 mouse pups and their CD1 foster mothers were exposed to a high oxygen environment (75% 02) from postnatal day 7 (P7) to P12. At P12, animals were injected intravitreally with 1 μl test compound (200, 20, or 2 uM) formulated in 1% DMSO, 10% Tween-80, 20% PEG-400, and returned to room air until P17. Eyes were enucleated at P17 and retinas dissected for either vascular staining or qRT-PCR. To determine avascular or neovascular area, retinas were flatmounted, and stained with isolectin B4 (IB4) diluted 1:100 in 1 mM CaCl2. For quantitative measurement of senesecence markers (e.g., Cdkn2a, Cdkn1a, 116, Vegfa), qPCR was performed. RNA was isolated and cDNA was generated by reverse-transcription, which was used for qRT-PCR of the selected transcripts.

FIGS. 9A and 9B show that intravitreal (IVT) administration UBX1967 resulted in statistically significant improvement in the degree of neovascularization and vaso-obliteration at all dose levels.

FIGS. 10A and 10B show the relative abundance of several transcripts associated with senescence (p16, pai1) and human disease (vegf). Treatment with UBX1967 resulted in a 58%, 35%, and 24% reduction in p16, pai1, and vegf, respectively. Senescence-associated β-galactosidase (SA-BGal) activity was reduced by 17% after administration of UBX1967.

These results show that a single ocular injection of UBX1967 can functionally inhibit pathogenic angiogenesis and promote vascular repair in this key OIR disease model. We believe that efficacy of UBX1967 in the OIR model is due to elimination of senescent cells and accompanying SASP that propagates senescence in retinal cells and promotes neovascularization of retinal vessels.

Full text: Click here
Patent 2024
Aftercare angiogen Animal Model Animals beta-Galactosidase Blood Vessel Cardiac Arrest CDKN1A protein, human Cellular Senescence Diabetic Retinopathy DNA, Complementary Eye Figs Homo sapiens Isolectins Mice, Inbred C57BL Mothers Mus Oxygen pathogenesis Pathologic Neovascularization polyethylene glycol 400 Retina Retinal Diseases Retinal Neovascularization Retinal Vessels Retinopathy of Prematurity Reverse Transcription SERPINE1 protein, human Sulfoxide, Dimethyl Tween 80 TXN protein, human Vascular Diseases Vascular Endothelial Growth Factors Vision
The functional enrichment of the gene expression data was interpreted by employing Gene Set Enrichment Analysis (GSEA, http://www.broadinstitute.org/gsea/index.jsp). The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways associated with cellular senescence are displayed, as well as the functional enrichment of cell senescence-related lncRNAs with predictive significance.
Full text: Click here
Publication 2023
Cellular Senescence Gene Expression Genes Genome RNA, Long Untranslated
To construct a validated prognostic model, 609 glioma patients were randomly divided into training and testing cohorts. Ultimately, 306 patients were enrolled in the training cohort, and 303 patients were enrolled in the testing cohort. The key characteristics of each cohort are shown in Table 1. The SRlncRNA signature was derived based on the training cohort, and its potential to predict patient survival was validated utilizing the testing cohort and the whole cohort. We also confirmed the prognostic signature in the TCGA-LGG cohort, the TCGA-GBM cohort and the CGGA cohort (Supplementary Tables S1, S2).
The prognostic significance of cellular senescence-related lncRNAs was initially determined using univariate Cox regression. Least absolute shrinkage and selection operator (LASSO) regression was used to integrate the cellular senescence-related lncRNAs with p < 0.05 in univariate analysis. The LASSO results were then included in a multivariate Cox model to generate a risk score. A risk score was calculated using a linear combination of cellular senescence-related lncRNA expression levels multiplied by a regression coefficient (β): risk score = i=1nβi× (expression of lncRNAi). Based on the median risk score, the patients were categorized into high-risk and low-risk groups. The log-rank test was used to compare the survival differences between the two groups.
Full text: Click here
Publication 2023
Cellular Senescence Glioma Patients Population at Risk RNA, Long Untranslated

Top products related to «Cellular Senescence»

Sourced in United States, Japan, United Kingdom, Germany
The Senescence β-Galactosidase Staining Kit is a laboratory tool used to detect and quantify senescent cells. The kit provides reagents and protocols for the histochemical detection of senescence-associated β-galactosidase activity, a widely used biomarker for cellular senescence.
Sourced in China
The SA-β-gal staining kit is a laboratory tool used to detect the presence of senescence-associated beta-galactosidase (SA-β-gal) activity in cells. SA-β-gal is a biomarker commonly used to identify senescent cells. The kit provides the necessary reagents and protocols to perform this staining procedure.
Sourced in United States, Germany, United Kingdom, Poland
The Senescence Cells Histochemical Staining Kit is a laboratory instrument designed to detect and quantify senescent cells. It utilizes a histochemical staining method to identify cells expressing senescence-associated β-galactosidase activity, a biomarker for cellular senescence.
Sourced in China
The Senescence β-Galactosidase Staining Kit is a laboratory tool used to detect and quantify senescent cells in a sample. The kit provides the necessary reagents to perform a histochemical staining procedure that identifies the presence of the senescence-associated β-galactosidase enzyme, a widely used biomarker for cellular senescence.
Sourced in United States, United Kingdom
The Senescence Detection Kit is a laboratory tool used to identify and measure senescent cells in a sample. It provides a standardized and reliable method for detecting senescence-associated beta-galactosidase (SA-β-gal) activity, a widely recognized marker of cellular senescence. The kit includes all the necessary components to perform this analysis.
Sourced in United States, Germany
The Cellular Senescence Assay Kit is a laboratory instrument designed to measure and analyze cellular senescence, a fundamental biological process. The kit provides a standardized and reliable method for the detection and quantification of senescent cells in various cell types and samples.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States
The SA-β-gal staining kit is a laboratory tool used for the detection and quantification of senescence-associated beta-galactosidase (SA-β-gal) activity in cells. SA-β-gal is a well-established biomarker for cellular senescence.
Sourced in United States
The Cellular Senescence Assay Kit is a laboratory tool designed to measure cellular senescence, a biological process where cells permanently cease to divide. The kit provides the necessary reagents and protocols to quantify the senescence-associated beta-galactosidase (SA-β-gal) activity, a widely used marker for identifying senescent cells.
Sourced in United States
The β-galactosidase staining kit is a laboratory tool used to detect and visualize the presence of the β-galactosidase enzyme in cells or tissues. The kit contains the necessary reagents and protocols to perform this staining procedure.

More about "Cellular Senescence"

Cellular senescence is a fundamental biological process characterized by the gradual deterioration and permanent arrest of cell division.
This phenotype is triggered by various intrinsic and extrinsic factors, such as telomere attrition, DNA damage, oxidative stress, and oncogenic signaling.
Senescent cells exhibit distinct morphological and functional changes, including enlarged and flattened morphology, increased senescence-associated β-galactosidase (SA-β-gal) activity, and the secretion of a pro-inflammatory senescence-associated secretory phenotype (SASP).
Cellular senescence plays a crucial role in organismal aging, tissue homeostasis, and the development of age-related diseases.
Understanding the mechanisms and regulators of cellular senescence is crucial for developing targeted interventions to mitigate the detrimental effects of this process and promote healthy aging.
The study of cellular senescence has important implications for fields such as regenerative medicine, cancer biology, and age-related disease research.
Researchers can leverage various tools and assays to study cellular senescence, including the Senescence β-Galactosidase Staining Kit, SA-β-gal staining kit, Senescence Cells Histochemical Staining Kit, Senescence Detection Kit, and Cellular Senescence Assay Kit.
These kits often utilize the increased activity of β-galactosidase, a hallmark of senescent cells, to detect and quantify senescent cell populations.
Additionally, fetal bovine serum (FBS) can be used in cell culture to support the growth and maintenance of senescent cells.
By incorporating these insights and related terms, researchers can optimize their cellular senescence research and uncover new strategies for promoting healthy aging and mitigating age-related diseases.